Business
LevelJump Announces 2025 First Quarter Results; Anticipates Revocation of Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - June 23, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP)
...
About this update from Leveljump Healthcare Corp.
[{"type":"text","content":"LevelJump Announces 2025 First Quarter Results; Anticipates Revocation of Cease Trade OrderToronto, Ontario--(Newsfile Corp. - June 23, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) (\"LevelJump\" or the \"Company\") is pleased to announce its financial results for the three months ended March 31, 2025.Financial and Operational HighlightsRevenues were $4.58 million in the first quarter of 2025 compared to $4.06 million in the same period of 2024, a year over year revenue increase of 12.8%.Canadian Teleradiology Services, Inc., the Company's 100% owned subsidiary had EBITDA for the first quarter of 2025 of $1.03 million. 2025 First Quarter Financial ResultsRevenues of $4.58 million in Q1 2025 with a net profit of $200,566.EBITDA of $898,017 for Q1 2025.Subsequent EventsSubsequent to the end of the quarter, the Company entered into an agreement to acquire two additional diagnostic imaging outpatient clinics located in Calgary, Alberta. The transaction is expected to close towards the end of July 2025. See the Company's news release dated June 13, 2025.Management CommentsMitch Geisler, CEO, commented, \"We are very pleased with our strong Q1 results and year-over-year growth. Our focus will remain on driving revenue and enhancing profitability.\"Company Anticipates Revocation of CTOWith the filing of its three month interim financial statements and related MD&A, the Company is now current with its continuous disclosure obligations. As a result, it is anticipated that the outstanding cease trade order issued by the Ontario Securities Commission will be revoked in the very near future at which time the Company's common shares will be eligible for reinstatement of trading on the TSX Venture Exchange (the \"Exchange\"). The Company has already made certain pre-filing submissions with the Exchange to ensure that trading resumes as soon as possible.Non-IFRS Financial MeasuresThis news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be compara...